We received feedback that this information is especially relevant considering recent AHRQ announcement "that articulated that Spiriva had superior mortality data over theophylline."
For more information, see the following AHRQ reports:
1.
Outcomes Associated with Tiotropium Use in Chronic Obstructive Pulmonary Disease Patients
2.
Mortality Risk in Chronic Obstructive Pulmonary Disease Patients Using Theophylline